FDA Approves Gleevec for Type of Childhood Leukemia
The US Food and Drug Administration (FDA) has approved Gleevec (imatinib) to treat children who are newly diagnosed with a form of acute lymphoblastic leukemia (ALL).
Study Helps Define Treatment Options in Children With Hard-to-Treat Leukemias
For some children with acute lymphocytic leukemia (ALL) who don’t improve after initial induction therapy, more chemotherapy may work better than a stem cell transplant, according to a study.
CT Scans in Children Raise Risk of Cancer
Computed tomography (CT) scans in children have been linked to a small increased risk for later developing leukemia and brain cancer, according to a newly published study by international researchers.
Childhood Leukemia Survival Rates Improve Significantly
A new study shows that children with the most common type of childhood cancer, acute lymphoblastic leukemia (ALL) have a survival rate of more than 90%.
Manufacturer Releasing Emergency Supplies of Methotrexate
A maker of the cancer drug methotrexate, Bedford Laboratories, has advised the FDA that it will release emergency supplies of preservative-free methotrexate to meet patients’ needs.
Experts See Progress, Hope in Battle Against Childhood Cancers
Survival has improved dramatically for kids with cancer over the past 30 years.